These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Cellular regulation of RGS proteins: modulators and integrators of G protein signaling. Hollinger S; Hepler JR Pharmacol Rev; 2002 Sep; 54(3):527-59. PubMed ID: 12223533 [TBL] [Abstract][Full Text] [Related]
44. Bench to bedside and back again: molecular mechanisms of alpha-catenin function and roles in tumorigenesis. Benjamin JM; Nelson WJ Semin Cancer Biol; 2008 Feb; 18(1):53-64. PubMed ID: 17945508 [TBL] [Abstract][Full Text] [Related]
45. Involvement of the Akt/PKB signaling pathway with disease processes. Sen P; Mukherjee S; Ray D; Raha S Mol Cell Biochem; 2003 Nov; 253(1-2):241-6. PubMed ID: 14619975 [TBL] [Abstract][Full Text] [Related]
47. Exploring Dysregulated Signaling Pathways in Cancer. Nisar S; Hashem S; Macha MA; Yadav SK; Muralitharan S; Therachiyil L; Sageena G; Al-Naemi H; Haris M; Bhat AA Curr Pharm Des; 2020; 26(4):429-445. PubMed ID: 31939726 [TBL] [Abstract][Full Text] [Related]
48. Oncogenic KRAS signalling promotes the Wnt/β-catenin pathway through LRP6 in colorectal cancer. Lemieux E; Cagnol S; Beaudry K; Carrier J; Rivard N Oncogene; 2015 Sep; 34(38):4914-27. PubMed ID: 25500543 [TBL] [Abstract][Full Text] [Related]
49. RAC-LATS1/2 signaling regulates YAP activity by switching between the YAP-binding partners TEAD4 and RUNX3. Jang JW; Kim MK; Lee YS; Lee JW; Kim DM; Song SH; Lee JY; Choi BY; Min B; Chi XZ; Bae SC Oncogene; 2017 Feb; 36(7):999-1011. PubMed ID: 27425596 [TBL] [Abstract][Full Text] [Related]
50. Metabolic Regulation of Apoptosis in Cancer. Matsuura K; Canfield K; Feng W; Kurokawa M Int Rev Cell Mol Biol; 2016; 327():43-87. PubMed ID: 27692180 [TBL] [Abstract][Full Text] [Related]
51. Discovery of a Novel Small-Molecule Inhibitor that Targets PP2A-β-Catenin Signaling and Restricts Tumor Growth and Metastasis. Maheshwari S; Avula SR; Singh A; Singh LR; Palnati GR; Arya RK; Cheruvu SH; Shahi S; Sharma T; Meena S; Singh AK; Kant R; Riyazuddin M; Bora HK; Siddiqi MI; Gayen JR; Sashidhara KV; Datta D Mol Cancer Ther; 2017 Sep; 16(9):1791-1805. PubMed ID: 28500231 [TBL] [Abstract][Full Text] [Related]
52. Effect of casein kinase 1α inhibition on autophagy flux and the AKT/phospho-β-catenin (S552) axis in HCT116, a RAS-mutated colorectal cancer cell line. Behrouj H; Seghatoleslam A; Mokarram P; Ghavami S Can J Physiol Pharmacol; 2021 Mar; 99(3):284-293. PubMed ID: 33635146 [TBL] [Abstract][Full Text] [Related]
53. Regulation of FOXO3a/beta-catenin/GSK-3beta signaling by 3,3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in prostate cancer cells. Li Y; Wang Z; Kong D; Murthy S; Dou QP; Sheng S; Reddy GP; Sarkar FH J Biol Chem; 2007 Jul; 282(29):21542-50. PubMed ID: 17522055 [TBL] [Abstract][Full Text] [Related]
54. STAT signaling in the pathogenesis and treatment of cancer. Frank DA Mol Med; 1999 Jul; 5(7):432-56. PubMed ID: 10449805 [TBL] [Abstract][Full Text] [Related]
55. 14-3-3 Proteins: a window for a deeper understanding of fungal metabolism and development. Shi L; Ren A; Zhu J; Yu H; Jiang A; Zheng H; Zhao M World J Microbiol Biotechnol; 2019 Jan; 35(2):24. PubMed ID: 30666471 [TBL] [Abstract][Full Text] [Related]
56. Protein Kinase-Mediated Decision Between the Life and Death. Engin A Adv Exp Med Biol; 2021; 1275():1-33. PubMed ID: 33539010 [TBL] [Abstract][Full Text] [Related]
57. 14-3-3 proteins: do they have a role in human cancer? Martinez JD Future Oncol; 2005 Oct; 1(5):631-3. PubMed ID: 16556040 [TBL] [Abstract][Full Text] [Related]
58. Distinctive microRNA signature associated of neoplasms with the Wnt/β-catenin signaling pathway. Sun X; He Y; Huang C; Ma TT; Li J Cell Signal; 2013 Dec; 25(12):2805-11. PubMed ID: 24041653 [TBL] [Abstract][Full Text] [Related]
59. The Translational Controlled Tumour Protein TCTP: Biological Functions and Regulation. Bommer UA Results Probl Cell Differ; 2017; 64():69-126. PubMed ID: 29149404 [TBL] [Abstract][Full Text] [Related]
60. A Wnt-ow of opportunity: targeting the Wnt/beta-catenin pathway in breast cancer. Prosperi JR; Goss KH Curr Drug Targets; 2010 Sep; 11(9):1074-88. PubMed ID: 20545611 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]